Form 8.3 - [AbbVie Inc.]
January 17 2020 - 9:38AM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 16(th) January 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 69,033,038 4.66782%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 69,033,038 4.66782%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 200 89.26
-------------- ----------------------------- -----------------------
Purchase 9,756 89.23
-------------- ----------------------------- -----------------------
Purchase 371 89.31
-------------- ----------------------------- -----------------------
Purchase 5,500 89.26
-------------- ----------------------------- -----------------------
Purchase 600 89.26
-------------- ----------------------------- -----------------------
Purchase 100 89.55
-------------- ----------------------------- -----------------------
Purchase 200 89.26
-------------- ----------------------------- -----------------------
Purchase 78 89.44
-------------- ----------------------------- -----------------------
Purchase 48,060 89.26
-------------- ----------------------------- -----------------------
Purchase 232 89.26
-------------- ----------------------------- -----------------------
Purchase 116 89.26
-------------- ----------------------------- -----------------------
Purchase 9,380 89.26
-------------- ----------------------------- -----------------------
Purchase 17,822 89.26
-------------- ----------------------------- -----------------------
Purchase 206 89.26
-------------- ----------------------------- -----------------------
Purchase 180 89.26
-------------- ----------------------------- -----------------------
Purchase 1,535 89.23
-------------- ----------------------------- -----------------------
Purchase 40 89.37
-------------- ----------------------------- -----------------------
Purchase 1,112 89.26
-------------- ----------------------------- -----------------------
Sale 600 89.26
-------------- ----------------------------- -----------------------
Sale 200 89.26
-------------- ----------------------------- -----------------------
Sale 200 89.26
-------------- ----------------------------- -----------------------
Sale 2,600 89.21
-------------- ----------------------------- -----------------------
Sale 2,499 89.26
-------------- ----------------------------- -----------------------
Sale 22,250 89.26
-------------- ----------------------------- -----------------------
Sale 15,880 89.26
-------------- ----------------------------- -----------------------
Sale 384 89.26
-------------- ----------------------------- -----------------------
Sale 8,616 89.26
-------------- ----------------------------- -----------------------
Sale 1,600 89.26
-------------- ----------------------------- -----------------------
Sale 100 89.26
-------------- ----------------------------- -----------------------
Sale 200 89.24
-------------- ----------------------------- -----------------------
Sale 600 89.26
-------------- ----------------------------- -----------------------
Sale 169 89.26
-------------- ----------------------------- -----------------------
Sale 152 89.26
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -------------------
Date of disclosure 17(th) January 2020
------------------------------------------------------- -------------------
Contact name Lionel Colaco
------------------------------------------------------- -------------------
Telephone number 020 33956098
------------------------------------------------------- -------------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -------------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -------------------
(END) Dow Jones Newswires
January 17, 2020 09:23 ET (14:23 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Sep 2023 to Sep 2024